VitaNova Life Sciences Corp (VNOV)
About VitaNova Life Sciences Corp
VITANOVA LIFE SCIENCES
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $2.7M
- Net income
- $850.7K
- Total assets
- $2.3M
Source: SEC EDGAR · updated Jun 7, 2026
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
VitaNova Life Sciences Corp (VNOV) Stock Price
- Profitable — net income of $850.7K in FY2025.
- Trading near its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review VitaNova Life Sciences Corp.
Write a review
VitaNova Life Sciences Corp: frequently asked questions
Is VitaNova Life Sciences Corp an American company?
VitaNova Life Sciences Corp is a US-based company headquartered in New York, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is VitaNova Life Sciences Corp headquartered?
VitaNova Life Sciences Corp is headquartered in New York, New York, United States.
Is VitaNova Life Sciences Corp publicly traded?
Yes — VitaNova Life Sciences Corp is a publicly traded company. Its stock trades under the ticker symbol VNOV on the OTC.
